Efficacy and safety of the cathepsin K inhibitor, ONO-5334, and alendronate on post-menopausal osteopenia or osteoporosis: 2-year results from ocean study

被引：0
|
作者：
Eastell, R. [1 ]
Nagase, S. [2 ]
Boonen, S. [3 ]
Spector, T. [4 ]
Small, M. [2 ]
Kuwayama, T. [2 ]
Sawyer, J. [5 ]
Deacon, S. [2 ]
机构：
[1] No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England
[2] Ono Pharma UK Ltd, Clin Dev, London, England
[3] Katholieke Univ Leuven, Leuven, Belgium
[4] Kings Coll London, London WC2R 2LS, England
[5] Prism Biodev Ltd, Nantwich, Cheshire, England
来源：
BONE | 2011年 / 48卷
关键词：
D O I：
10.1016/j.bone.2011.03.131
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S92 / S93
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study
    Iain B. McInnes
    Koji Kato
    Marina Magrey
    Joseph F. Merola
    Mitsumasa Kishimoto
    Derek Haaland
    Liang Chen
    Yuanyuan Duan
    Jianzhong Liu
    Ralph Lippe
    Peter Wung
    Rheumatology and Therapy, 2023, 10 : 275 - 292
  • [22] Sustained clinical efficacy and safety of adalimumab in patients with moderate to severe psoriatic arthritis (PsA): 2-year results from an openlabel extension study
    Mease, Philip
    Ritchlin, Christopher
    Wong, Robert
    Gladman, Dafna
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB4 - AB4
  • [23] Safety and clinical efficacy outcomes from the Long-term extension study of tolebrutinib in patients with relapsing multiple sclerosis: 2-year results
    Oh, J.
    Syed, S.
    Orogun, L.
    Xu, Z.
    Turner, T. J.
    Fox, R. J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 342 - 343
  • [24] Long-term safety and efficacy of the DPP-4 inhibitor linagliptin: data from a large 2-year study in subjects with type 2 diabetes mellitus
    Schlosser, A.
    Owens, D.
    Taskinen, M. -R.
    Del Prato, S.
    Gomis, R.
    Patel, S.
    Pivovarova, A.
    Woerle, H. -J.
    DIABETOLOGIA, 2011, 54 : S108 - S108
  • [25] Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study
    Smolen, Josef S.
    Burmester, Gerd-Ruediger
    Combe, Bernard
    Curtis, Jeffrey R.
    Hall, Stephen
    Haraoui, Boulos
    van Vollenhoven, Ronald
    Cioffi, Christopher
    Ecoffet, Cecile
    Gervitz, Leon
    Ionescu, Lucian
    Peterson, Luke
    Fleischmann, Roy
    LANCET, 2016, 388 (10061): : 2763 - 2774
  • [26] LONG-TERM SAFETY AND EFFICACY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC): 2-YEAR RESULTS FROM A LONG-TERM STUDY
    Mayo, Marlyn J.
    Vierling, John M.
    Bowlus, Christopher L.
    Neff, Guy W.
    Galambos, Michael R.
    Gordon, Stuart C.
    Borg, Brian
    Levy, Cynthia
    Harrison, Stephen A.
    Thuluvath, Paul J.
    Goel, Aparna
    Shiffman, Mitchell L.
    Steinberg, Alexandra
    Xu, Emily
    Yang, Ke
    Choi, Yun-Jung
    Dickinson, Klara
    McWherter, Charles
    HEPATOLOGY, 2021, 74 : 71A - 73A
  • [27] LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PSA 1 STUDY
    Mcinnes, I.
    Kato, K.
    Magrey, M.
    Merola, J. F.
    Kishimoto, M.
    Haaland, D.
    Chen, L.
    Duan, Y.
    Liu, J.
    Lippe, R.
    Wung, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 260 - 261
  • [28] Sustained clinical efficacy and safety of adalimumab in patients with moderate to severe psoriatic arthritis: 2-year results from PSA study M02-537
    Mease, P. J.
    Genovese, M.
    Ritchlin, C. T.
    Van den Bosch, F.
    Wellborne, F.
    Birbara, C.
    Thomson, G.
    Perdok, R.
    Medich, J.
    Wong, R.
    Gladman, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 419 - 419
  • [29] Long-term safety and efficacy of intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis type II: 2-year results from a phase 2/3 extension study
    Muenzer, Joseph
    Burton, Barbara K.
    Harmatz, Paul
    Gonzalez Gutierrez-Solana, Luis
    Ruiz-Garcia, Matilde
    Jones, Simon A.
    Guffon, Nathalie
    Inbar-Feigenberg, Michal
    Bratkovic, Drago
    Li, Xiaoxi
    Yee, Karen S.
    Alexanderian, David
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S73 - S74
  • [30] Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study
    Nauck, M.
    Frid, A.
    Hermansen, K.
    Thomsen, A. B.
    During, M.
    Shah, N.
    Tankova, T.
    Mitha, I.
    Matthews, D. R.
    DIABETES OBESITY & METABOLISM, 2013, 15 (03): : 204 - 212
12345